Skip to main content

Dr. Jane S. Chawla, MD

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
21
In the NPI registry since
2007
Medicare patients seen, 2024
648

Licensed in Texas since 2008, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2005Medical school: University of Texas Medical School at San Antonio
  • 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    TX license M8590 (first issued 2008; active)
  • Internal Medicine Physician
    TX license M8590 (first issued 2008; active)
  • Medical Oncology Physician
    TX license M8590 (first issued 2008; active)
  • Student in an Organized Health Care Education/Training Program

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
648
Services billed
154,100
Patients’ average age
74
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, fosaprepitant, 1 mg15,15045
Injection, pembrolizumab, 1 mg11,80027
Injection, iron sucrose, 1 mg11,30031
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)10,20012
Injection, paclitaxel, 1 mg10,18224
Injection, oxaliplatin, 0.5 mg9,30011
Injection, darbepoetin alfa, 1 microgram (non-esrd use)8,84014
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml7,55070
Injection, aprepitant, 1 mg3,51015
Injection, denosumab, 1 mg2,70016

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 2 companies reported 2 payments worth $50.25 in total to this clinician.

By company
Progenics Pharmaceuticals, Inc.$27.41
Janssen Biotech, Inc.$22.84
By type
Food and Beverage$50.25

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Texas →

Other Hematology & Oncology clinicians in Austin

Sources

NPI registry (CMS NPPES, November 2026; record last updated September 17, 2024), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1487863304. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.